As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...